Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism.

Moore MC, Smith MS, Sinha VP, Beals JM, Michael MD, Jacober SJ, Cherrington AD
Diabetes. 2014 63 (2): 494-504

PMID: 24089512 · PMCID: PMC5361402 · DOI:10.2337/db13-0826

MeSH Terms (11)

Animals Blood Glucose Dogs Glucose Humans Hypoglycemic Agents Insulin Lispro Insulins Lactic Acid Liver Polyethylene Glycols

Connections (3)

This publication is referenced by other Labnodes entities:

Links